How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Weight-loss Use Intragastric Balloon Market
- By Balloon Type: Single Fluid-Filled Balloon, Dual Fluid-Filled Balloon, Air-Filled Balloon, Adjustable Balloon
- By Procedure Setting: Outpatient Clinic, Hospital Inpatient, Ambulatory Surgical Center
- By Patient BMI Category: Overweight (BMI 25-29.9), Obese Class I (BMI 30-34.9), Obese Class II (BMI 35-39.9), Obese Class III (BMI ≥40)
- By Duration of Implantation: Short-Term (up to 6 months), Medium-Term (6-12 months), Long-Term (over 12 months)
- By End-User: Bariatric Clinics, Gastroenterology Centers, Weight Management Centers, General Hospitals
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Single Fluid-Filled Balloon leads By Balloon Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 12 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 282 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.174 →
- 12 Company Profiles 12 players: SWOT & benchmarking p.182 →
Full report · locked preview
Everything inside the Weight-loss Use Intragastric Balloon Market report
A complete, evidence-based study - 12 chapters and 118 sections covering market size, segmentation across 5 axes, regional analysis and 12 company profiles, forecast to 2033.
Segmentation covered
Balloon Type 4
Procedure Setting 3
Patient BMI Category 4
Duration of Implantation 3
End-User 4
Companies profiled
Apollo Endosurgery Inc.
ReShape Lifesciences Inc.
Allurion Technologies
Obalon Therapeutics Inc.
GI Dynamics Inc.
Spatz Medical Inc.
Lexington Medical Inc.
Medtronic plc
Bariatric Solutions Inc.
Endalis
BaroNova
Elipse Balloon (Allurion Technologies)
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
12 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Apollo Endosurgery Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →ReShape Lifesciences Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Allurion Technologies
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Obalon Therapeutics Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →GI Dynamics Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Spatz Medical Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Lexington Medical Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Medtronic plc
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Bariatric Solutions Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Endalis
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.209 →BaroNova
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →Elipse Balloon (Allurion Technologies)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$3,617M by 2033 · 7.7% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Single Fluid-Filled Balloon56.7
- Dual Fluid-Filled Balloon15.8
- Air-Filled Balloon18.9
- Adjustable Balloon8.6
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$658.5M → $1,150M · 7.2%
Europe$458.9M → $791.3M · 7.0%
Asia Pacific$419.0M → $733.1M · 7.2%
Latin America$259.4M → $464.7M · 7.6%
Middle East and Africa$199.5M → $397.6M · 9.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →7.672026
7.692027
7.702028
7.712029
7.712030
7.722031
7.742032
7.752033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Apollo Endosurgery Inc.19.4
- ReShape Lifesciences Inc.24.1
- Allurion Technologies13.7
- Obalon Therapeutics Inc.4.3
- GI Dynamics Inc.4.1
- Spatz Medical Inc.6.4
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Balloon Type16.2%
Procedure Setting21.4%
Patient BMI Category25.6%
Duration of Implantation25.2%
End-User11.6%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.5
- Europe22.4
- Asia Pacific20.7
- Latin America13.1
- Middle East and Africa11.2
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Apollo Endosurgery Inc. | 86 | 98 | 99 | 76 | 80 | 94 | 89 |
| ReShape Lifesciences Inc. | 71 | 92 | 79 | 78 | 86 | 83 | 82 |
| Allurion Technologies | 66 | 64 | 78 | 81 | 63 | 62 | 69 |
| Obalon Therapeutics Inc. | 77 | 69 | 72 | 76 | 65 | 63 | 70 |
| GI Dynamics Inc. | 72 | 64 | 58 | 53 | 53 | 56 | 59 |
| Spatz Medical Inc. | 48 | 60 | 61 | 59 | 58 | 71 | 60 |
| Lexington Medical Inc. | 52 | 47 | 59 | 47 | 43 | 44 | 49 |
| Medtronic plc | 47 | 44 | 37 | 36 | 39 | 40 | 41 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Apollo Endosurgery Inc.
- ReShape Lifesciences Inc.
- Allurion Technologies
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Apollo Endosurgery Inc. | ✓ | ✓ | ✓ | ✓ | ◐ | ✓ |
| ReShape Lifesciences Inc. | ◐ | ✓ | ✓ | ✓ | ✓ | ◐ |
| Allurion Technologies | ◐ | ◐ | ◐ | ✓ | ◐ | ✓ |
| Obalon Therapeutics Inc. | ◐ | − | ✓ | ◐ | ◐ | − |
| GI Dynamics Inc. | ◐ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Spatz Medical Inc. | − | ◐ | ◐ | ◐ | ◐ | ◐ |
| Lexington Medical Inc. | − | − | ◐ | − | − | − |
| Medtronic plc | − | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Apollo Endosurgery Inc.89
2ReShape Lifesciences Inc.82
3Obalon Therapeutics Inc.70
4Allurion Technologies69
5Spatz Medical Inc.60
6GI Dynamics Inc.59
7Lexington Medical Inc.49
8Medtronic plc41
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Apollo Endosurgery Inc.ReShape Lifesciences Inc.
Challenger2
Strong scale, closing on the leaders.
Allurion TechnologiesObalon Therapeutics Inc.
Contender2
Focused players with pockets of strength.
GI Dynamics Inc.Spatz Medical Inc.
Niche2
Specialists in a single segment or region.
Lexington Medical Inc.Medtronic plc
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Balloon Type in North America, then scale across Weight-loss Use Intragastric Balloon Market — a $475M beachhead inside a $7.35B market.
Beachhead (SOM)$475Mobtainable near-term
Serviceable (SAM)$2.84Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Single Fluid-Filled Balloon
Best fit — highest urgency & budget in Balloon Type.
Economic buyer76 fit
Dual Fluid-Filled Balloon
Strong fit — clear ROI and a fast path to value.
End user65 fit
Air-Filled Balloon
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Balloon Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Procedure Setting & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Patient BMI Category
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel29%
Digital / self-serve20%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Balloon Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Weight-loss Use Intragastric Balloon Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified39%
Sales qualified21%
Evaluation12%
Closed-won5%
$22.0KCAC
$130KLTV
5.9:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Weight-loss Use Intragastric Balloon Market is a durable-growth opportunity — $7.15B by 2033, compounding at 8.9%.
TAM · 2025$3.61Btoday
TAM · 2033$7.15Bforecast
CAGR8.9%2027–2033
Cumulative$46.8Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.15BTotal addressable market
SAM$2.90BServiceable available market
SOM$541MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.9% CAGR
Demand compounds through 2033, outpacing GDP across Balloon Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Balloon Type moving from early to mainstream — durable secular demand.
Consolidation upside
12+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.15BLarge & growingTAM by 2033 at 8.9% CAGR
$2.90BServiceable nowreachable with today’s model
$541MBeachhead winobtainable near-term share
12+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.58BBear5.8% CAGR
$7.15BBase8.9% CAGR
$9.16BBull11.8% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Procedure Setting optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Weight-loss Use Intragastric Balloon Market — a $4.43B market by 2033. Plan: grow share from 10.6% to 18.1%.
Market size · 2033$4.43Btotal addressable
Market CAGR6.6%2027–2033
Target share18.1%from 10.6% today
Revenue ambition$802Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 10.6% | 18.1% | On track |
| Revenue | $458M | $802M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 35.9% | 43.8% | Behind |
| Customer retention | 91.2% | 93.0% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Balloon Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Procedure Setting capability
A defensible second engine — invest in Procedure Setting to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Balloon Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Procedure Setting
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $83M capacity & capability investment
- Greenlight bolt-on M&A in Procedure Setting
- Authorise North America expansion plan
- Fund R&D program for Balloon Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossBehind
- Input-cost & supply riskOn track
- Regulatory / policy changeBehind
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Weight-loss Use Intragastric Balloon Market conversation — a $2.08B market you can size, segment and defend in minutes.
Market size · 2033$2.08Btotal opportunity
Growth11.5%CAGR to 2033
Addressable buyers1,654+accounts in scope
Typical ROI6.9×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Balloon Type
Goal Grow share in Balloon Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.9×return on cost, year one
< 3 mopayback period
$82K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
12+players profiled in this market
Coverage includes
Apollo Endosurgery Inc.ReShape Lifesciences Inc.Allurion TechnologiesObalon Therapeutics Inc.GI Dynamics Inc.Spatz Medical Inc.Lexington Medical Inc.Medtronic plc+4 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Weight-loss Use Intragastric Balloon Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Weight-loss Use Intragastric Balloon Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Weight Loss Software Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportWeight Loss Health Chewing Gum Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportWeight Loss Camp Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportWeight Loss Balloon Market
Market size, share, segmentation and regional forecast.
$587M market · 2025 base year
View reportWeight Loss and Weight Management Device Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportWeight Gain App Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportWeighted Safety Scalpel Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportWeight Dosing Dispenser Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportWeight Data-loggers Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportWeight Controllers Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportWeight Checkers for Capsules and Tablets Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportWeighing Papers Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.